Market Report, "Global Peptic Ulcer Drugs Market 2014-2018 ", Published
Fast Market Research recommends "Global Peptic Ulcer Drugs Market 2014-2018 " from TechNavio, now available
Boston, MA -- (SBWire) -- 09/10/2014 --A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.
TechNavio's analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018.
View Full Report Details and Table of Contents
Covered in this Report:
This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.
TechNavio's report, the Global Peptic Ulcer Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Peptic Ulcer Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
- Americas
- EMEA
- APAC
Key Vendors
- AstraZeneca plc
- Eisai Co. Ltd.
- Daewoong Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
Other Prominent Vendors
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- Eumedica
- Ferring Pharmaceuticals
- Horizon Pharma
- Johnson and Johnson
- Merck Sharp and Dohme
- Otsuka Holdings
- Pfizer
- PharmaKing
- Pozen
- Rottapharm Madaus
- Taiho Pharmaceutical
- Zeria Pharmaceutical
- Zuventus Healthcare
Market Driver
- Increased Incidence of H. pylori Infections.
- For a full, detailed list, view our report.
Market Challenge
- Adverse Effect of PPIs.
- For a full, detailed list, view our report.
Market Trend
- Use of Combination Drugs.
- For a full, detailed list, view our report.
Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Companies Mentioned in this Report: AstraZeneca plc, Eisai Co. Ltd., Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Daiichi Sankyo, Dr. Reddy's Laboratories, Eumedica, Ferring Pharmaceuticals, Horizon Pharma, Johnson and Johnson, Merck Sharp and Dohme, Otsuka Holdings, Pfizer, PharmaKing, Pozen, Rottapharm Madaus, Taiho Pharmaceutical, Zeria Pharmaceutical and Zuventus Healthcare
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 800-844-8156
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Duodenal Ulcer Global Clinical Trials Review, H2, 2013
- Peptic Ulcers Global Clinical Trials Review, H2, 2013
- Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H2, 2013
- Global Generic Drugs Market 2014-2018
- Global CRAMS Market Outlook to 2018 - India and China Present Bright Prospects
- Global Pain Management Drugs Market 2014-2018
- Global Multiple Sclerosis Drugs Market 2014-2018
- Global Dermatological Drugs Market 2014-2018
- Biosimilars Market - Global Forecast to 2018
- Global Orphan Drugs Market 2014-2018
Media Relations Contact
Bill Thompson
Director of Marketing
Fast Market Research, Inc.
800-844-8156
http://www.fastmr.com
View this press release online at: http://rwire.com/542037